| 영문 | fibrin | 한글 | 섬유소 |
|---|---|---|---|
| 설명 | 피가 굳을 때 섬유소에 트롬빈이 작용하여 생기는 섬유 같은 단백질. 무색이나 엷은 황색을 띤 고체로, 물에 잘 녹지 않으며 혈구와 엉키어 피를 굳게 하여 출혈을 그치게 한다. |
||
| 영문 | blood product | 한글 | 혈액제제 |
|---|---|---|---|
| 설명 | 1. 사람의 혈액을 성분별로 분리하여, 그것을 원료로 제조한 의약품. 악성 종양 따위에 수혈하는 적혈구, 백혈병-자색반병의 출혈을 멎게하는 혈소판, 화상의 치료에 쓰는 혈장, 산후 출혈을 멎게 하는 섬유소원 따위가 있다. 2. 사람의 혈액형을 검사하는데 쓰는 약. |
||
| FDP | fibrin degradation product; fibrinogen degradation product; flexor digitorum profundus; frontodextra... |
|---|---|
| PD | Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p... |
| FbDP | fibrin degradation products |
| SFC | soluble fibrin complex; soluble fibrin-fibrinogen complex; spinal fluid count |
| DP | data processing; deep pulse; definitive procedure; degradation product; degree of polymerization; de... |
| FDP | Fibrin Degradation Product |
|---|---|
| FDP | Fibrin(ogen) degradation product |
| FDP | Fibrin-fibrinogen degradation product |
| FbDP | Fibrin Degradation Products |
| FDP | Fibrinogen-Fibrin Degradation Products |
natural purification (자정 작용
| fibrin degradation products | <haematology, investigation> A test that measures fibrin degradation products which result from the dissolution of a blood clot. Normal value is less than 10 mcg/ml (micrograms per millilitre). They may be increased in conditions such as burns, placental abruption, heart disease, DIC, after massive blood transfusion, hypoxia, intrauterine foetal death, portacaval shunt, leukaemia, transfusion reaction, transplant rejection, sepsis, renal failure and preeclampsia. Acronym: FDP (23 Sep 2002) |
|---|
| fibrin fibrinogen degradation products | <chemical> Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. Fdp and their complexes profoundly impair the haemostatic process and are a major cause of haemorrhage in intravascular coagulation and fibrinolysis. Pharmacological action: antithrombins. (12 Dec 1998) |
|---|---|
| degradation | <biochemistry, chemistry> The reduction of a chemical compound to one less complex, as by splitting off one or more groups. (18 Nov 1997) |
| edman degradation | A lab technique used to find out the order of amino acids in a polypeptide (chain of amino acids). It involves using the Edman reagent, phenyl isothiocyanate (PITC), to react one by one with each amino acid, in order. The technique is used in machines which automatically sequence (determine the order of subunits) polypeptides. (09 Oct 1997) |
| human fibrin foam | A dry artificial sponge of human fibrin prepared by clotting with thrombin a foam of a solution of human fibrinogen; the clotted foam is dried from the frozen state and heated; used as a topical anticoagulant. (05 Mar 2000) |
| fibrin | <protein> The insoluble protein formed from fibrinogen by the proteolytic action of thrombin during normal clotting of blood. Fibrin forms the essential portion of the blood clot. (12 Nov 1997) |
| fibrin calculus | A urinary calculus formed largely from fibrinogen in blood. (05 Mar 2000) |
| fibrin destabilase | <enzyme> Hydrolyses the epsilon-(gamma-glutamyl)-lysine bonds of stabilised fibrin Pharmacological action: fibrinolytic agents Registry number: EC 3.4.99.- Synonym: destabilase (26 Jun 1999) |
| fibrin foam | <chemical> A dry artificial sterile sponge of fibrin prepared by clotting with thrombin a foam or solution of fibrinogen. It is used in conjunction with thrombin as a haemostatic in surgery at sites where bleeding cannot be controlled by more common methods. Pharmacological action: haemostatics, tissue adhesives. (12 Dec 1998) |
| fibrinogen-fibrin conversion syndrome | <syndrome> A syndrome characterised by hypofibrinogenaemia with incoagulable blood; it may be seen in abruptio placentae, prolonged retention of a dead foetus in an Rh-isosensitised mother, haemolytic blood reactions, bilateral renal cortical necrosis, and cases of trauma. (05 Mar 2000) |
| fibrin-stabilizing factor | <chemical> Fibrin stabilizing factor. It is a glycoprotein activated by thrombin in the presence of calcium to form factor xiiia. Factor xiii is found evenly distributed between plasma and platelets. Its function is to stabilise the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Chemical name: Blood-coagulation factor XIII (12 Dec 1998) |
| fibrin thrombus | A thrombus formed by repeated deposits of fibrin from the circulating blood; it usually does not completely occlude the vessel. (05 Mar 2000) |
| fibrin tissue adhesive | <chemical> An autologous or commercial tissue adhesive containing fibrinogen and thrombin. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, factor viii, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agent such as aprotinin. Mixing of the two components promotes clotting and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, haemostasis, and wound healing. Pharmacological action: haemostatics, tissue adhesives. (12 Dec 1998) |
| activation product | <radiobiology> The unstable nucleus formed when activation occurs. (See activation above.) (09 Oct 1997) |
| by-product | <chemistry> A product of a chemical reaction or industrial process which is different from the desired product. (20 Mar 1998) |
| by-product material | Radioactive material produced by nuclear fission or by neutron irradiation in a nuclear reactor or similar device. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|